List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 147 studies with search of:   "Carmustine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: surgical procedure
2 Completed Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Drug: irinotecan hydrochloride;   Drug: polifeprosan 20 with carmustine implant;   Procedure: surgical procedure
3 Active, not recruiting The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: IL13-PE38QQR;   Procedure: surgery and catheter placement (2 procedures);   Drug: prolifespan 20 with carmustine implant (GLIADEL® Wafer);   Procedure: surgery and wafer placement (1 procedure)
4 Recruiting Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer
Condition: Metastatic Brain Cancer
Intervention: Drug: Gliadel
5 Recruiting Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation
Conditions: Nausea;   Vomiting
Interventions: Drug: Carmustine, Etoposide, Cytarabine, Melphalan;   Drug: Aprepitant, Carmustine, Etoposide, Cytarabine, Melphalan
6 Recruiting Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
Condition: Lymphoma
Interventions: Drug: Carmustine;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Rituximab;   Drug: Bortezomib;   Other: Allogeneic Stem Cell Infusion
7 Not yet recruiting Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma
Condition: Anaplastic Astrocytoma
Interventions: Drug: trabedersen;   Drug: temozolomide or carmustine for infusion;   Device: Drug delivery system for administration of AP 12009;   Procedure: Placement of Drug Delivery System
8 Completed Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: iodine I 125;   Drug: polifeprosan 20 with carmustine implant;   Procedure: surgical procedure
9 Completed O6-Benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: O6-benzylguanine;   Drug: carmustine
10 Active, not recruiting O6-Benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: O6-benzylguanine;   Drug: carmustine
11 Recruiting Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lymphokine-activated killer cells;   Drug: polifeprosan 20 with carmustine implant
12 Completed Carmustine in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Procedure: conventional surgery
13 Completed Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Drug: Edotecarin;   Drug: Temozolomide;   Drug: Carmustine (BCNU);   Drug: Lomustine (CCNU)
14 Completed Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
15 Completed O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: conventional surgery
16 Active, not recruiting Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: conventional surgery
17 Completed Carmustine Plus O6-Benzylguanine in Treating Patients With Recurrent or Progressive Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: carmustine
18 Active, not recruiting Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: carmustine
19 Recruiting Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
Condition: Lymphoma
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: pharmacological study
20 Active, not recruiting Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: O6-benzylguanine;   Drug: carmustine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services